Investigation of Drug-drug Interaction Between Nintedanib and Pirfenidone in Patients With IPF (an Open Label, Multiple-dose, Two Group Study)
Phase of Trial: Phase IV
Latest Information Update: 02 May 2017
At a glance
- Drugs Nintedanib (Primary) ; Pirfenidone
- Indications Idiopathic pulmonary fibrosis
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 26 Apr 2017 Status changed from active, no longer recruiting to completed.
- 21 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Jan 2017 Planned End Date changed from 1 Feb 2017 to 1 Apr 2017.